Weybosset Research & Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $5.99M | Buy |
70,204
+497
| +0.7% | +$38.8K | 2.23% | 20 |
|
|
2021
Q3 | $5.27M | Buy |
69,707
+31
| +0% | +$2.46K | 2.14% | 20 |
|
|
2021
Q2 | $5.67M | Sell |
69,676
-489
| -0.7% | -$40K | 2.3% | 20 |
|
|
2021
Q1 | $5.53M | Buy |
70,165
+1,720
| +3% | +$135K | 2.28% | 20 |
|
|
2020
Q4 | $5.85M | Buy |
68,445
+2,001
| +3% | +$165K | 2.69% | 20 |
|
|
2020
Q3 | $5.13M | Buy |
66,444
+65
| +0.1% | +$4.96K | 2.81% | 18 |
|
|
2020
Q2 | $4.86M | Buy |
66,379
+40
| +0.1% | +$2.84K | 2.85% | 20 |
|
|
2020
Q1 | $4.31M | Sell |
66,339
-621
| -0.9% | -$43.8K | 3.07% | 17 |
|
|
2019
Q4 | $4.61M | Sell |
66,960
-1,969
| -3% | -$134K | 2.41% | 20 |
|
|
2019
Q3 | $5.07M | Buy |
68,929
+495
| +0.7% | +$35.9K | 2.9% | 20 |
|
|
2019
Q2 | $4.91M | Buy |
68,434
+390
| +0.6% | +$27.7K | 2.85% | 19 |
|
|
2019
Q1 | $4.66M | Buy |
68,044
+341
| +0.5% | +$22K | 2.74% | 19 |
|
|
2018
Q4 | $4.03M | Sell |
67,703
-45
| -0.1% | -$2.81K | 2.75% | 18 |
|
|
2018
Q3 | $4.54M | Buy |
67,748
+1,315
| +2% | +$87.6K | 2.61% | 19 |
|
|
2018
Q2 | $4.31M | Sell |
66,433
-119
| -0.2% | -$7.78K | 2.6% | 21 |
|
|
2018
Q1 | $4.77M | Buy |
66,552
+1,281
| +2% | +$92.2K | 2.87% | 17 |
|
|
2017
Q4 | $4.92M | Sell |
65,271
-993
| -1% | -$72.5K | 2.99% | 18 |
|
|
2017
Q3 | $4.83M | Sell |
66,264
-1,144
| -2% | -$82.5K | 3.21% | 17 |
|
|
2017
Q2 | $5M | Sell |
67,408
-85
| -0.1% | -$6.31K | 3.22% | 16 |
|
|
2017
Q1 | $4.94M | Buy |
67,493
+1,270
| +2% | +$88.9K | 3.34% | 15 |
|
|
2016
Q4 | $4.33M | Buy |
66,223
+1,565
| +2% | +$107K | 3.04% | 16 |
|
|
2016
Q3 | $4.79M | Sell |
64,658
-7,243
| -10% | -$535K | 3.47% | 17 |
|
|
2016
Q2 | $5.26M | Buy |
71,901
+1,985
| +3% | +$141K | 4.01% | 11 |
|
|
2016
Q1 | $4.94M | Sell |
69,916
-880
| -1% | -$58.5K | 4.18% | 9 |
|
|
2015
Q4 | $4.72M | Sell |
70,796
-14,134
| -17% | -$940K | 4.18% | 11 |
|
|
2015
Q3 | $5.39M | Sell |
84,930
-2,109
| -2% | -$138K | 4.02% | 11 |
|
|
2015
Q2 | $5.69M | Sell |
87,039
-1,510
| -2% | -$102K | 3.76% | 16 |
|
|
2015
Q1 | $6.14M | Sell |
88,549
-2,034
| -2% | -$141K | 3.88% | 15 |
|
|
2014
Q4 | $6.27M | Sell |
90,583
-34
| -0% | -$2.3K | 3.96% | 12 |
|
|
2014
Q3 | $5.91M | Sell |
90,617
-571
| -0.6% | -$37.7K | 3.99% | 11 |
|
|
2014
Q2 | $6.22M | Sell |
91,188
-2,031
| -2% | -$136K | 3.99% | 10 |
|
|
2014
Q1 | $6.05M | Sell |
93,219
-3,871
| -4% | -$244K | 4.02% | 11 |
|
|
2013
Q4 | $6.33M | Sell |
97,090
-3,832
| -4% | -$245K | 4.24% | 12 |
|
|
2013
Q3 | $5.99M | Sell |
100,922
-476
| -0.5% | -$28.2K | 4.42% | 11 |
|
|
2013
Q2 | $5.81M | Buy |
+101,398
| New | +$6.02M | 4.4% | 9 |
|
Other funds holding CL
Weybosset Research & Management's CL Position: Q4 2021 in Review
Weybosset Research & Management increased its Colgate-Palmolive (CL) stake by 0.71% in Q4 2021, buying an estimated $38.8K and bringing the position to 70,204 shares worth $5.99M. The position accounts for 2.23% of the portfolio, ranked #20.
Weybosset Research & Management first reported a position in CL in Q2 2013 and has held it in 35 quarters since. The position peaked at $6.33M in Q4 2013. 1,704 funds tracked by Wall St. Rank hold CL as of Q4 2021.
- Weybosset Research & Management held 70,204 shares of Colgate-Palmolive worth $5.99M as of Q4 2021.
- Weybosset Research & Management bought 497 Colgate-Palmolive shares in Q4 2021, an estimated $38.8K.
- Colgate-Palmolive made up 2.23% of Weybosset Research & Management's portfolio in Q4 2021, its #20 holding.
- Weybosset Research & Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 35 quarters since.
- Weybosset Research & Management's Colgate-Palmolive position peaked at $6.33M in Q4 2013.
- 1,704 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2021.
Based on Weybosset Research & Management's 13F filing for Q4 2021, filed 19 Jan 2022.